Retatrutide & Cagrilintide Pen (20mg/10mg)
£130.00
Storage Instructions
Store refrigerated at 2–8°C. Do not freeze. Protect from light.
Description
This research blend pen combines Retatrutide (20mg) and Cagrilintide (10mg). Retatrutide is a triple-agonist peptide targeting the GIP, GLP-1, and glucagon receptors simultaneously, while Cagrilintide is a long-acting acylated amylin analogue. The pre-filled pen provides a precision-dosed format for controlled laboratory dispensing in metabolic-signalling research.
Research Context
Preclinical research has examined Retatrutide's triagonist activity across GIP, GLP-1, and glucagon receptors and Cagrilintide's amylin-receptor signalling, including studies of their combined effects on metabolic pathways. Supplied exclusively for in vitro laboratory research purposes.
Reconstitution Guide
Open the calculator pre-loaded with this compound to plan reconstitution.
Related Research
Research guides for this compound are coming soon. Browse our full library at /guides.
Related Products
This product is supplied for in-vitro laboratory research only. Not for human consumption, medical treatment, or cosmetic use.
Disclaimer for Elv8 Wellness Purchase
By purchasing from Elv8 Wellness, you acknowledge and agree that:
- Research Use Only: All products are exclusively sold for research purposes. They are not intended for human use, therapeutic, diagnostic, or clinical application.
- Not Medical Products: None of the products listed on our website are medical products, nor should they be marketed or used as such.
- Compliance and Responsibility: The buyer is responsible for ensuring compliance with all relevant laws and regulations. Elv8 Wellness holds no liability for misuse of products or any adverse outcomes.
Your purchase signifies your understanding and agreement to these terms.